This inventor holds 4 USPTO granted patents. Top assignee: Institut Pasteur. Active years: 2000-2007.
Company Filing History:
Years Active: 2000-2007
Title: Claude Oeuvray: Innovator in Antibody Research
Introduction
Claude Oeuvray is a prominent inventor based in Paris, France. He has made significant contributions to the field of immunology, particularly in the development of antibodies that target specific proteins. With a total of 4 patents to his name, Oeuvray's work has implications for vaccine development and therapeutic interventions.
Latest Patents
Oeuvray's latest patents include innovative approaches to purified polyclonal and monoclonal antibodies. One of his notable inventions relates to an antibody that recognizes an epitope of a protein weighing 48,000 daltons. This protein is a surface protein of a merozoite, which has a peptide sequence of SEQ ID NO:1. The invention also covers modifications of this sequence that inhibit the binding of monoclonal antibody 245 to merozoites. Additionally, he has developed compositions and kits that utilize these antibodies, along with methods for their application. Another patent focuses on Plasmodium falciparum antigens that induce protective antibodies, further showcasing his expertise in this critical area of research.
Career Highlights
Oeuvray is affiliated with the prestigious Institut Pasteur, where he conducts his research. His work at this renowned institution has allowed him to explore various aspects of immunology and contribute to advancements in the field. His innovative research has garnered attention and respect within the scientific community.
Collaborations
Throughout his career, Oeuvray has collaborated with esteemed colleagues such as Pierre Druilhe and Hasnaq Bouharoun-Tayoun. These collaborations have enriched his research and expanded the impact of his inventions.
Conclusion
Claude Oeuvray is a distinguished inventor whose work in antibody research has the potential to influence vaccine development and therapeutic strategies. His contributions to the field are invaluable, and his ongoing research continues to pave the way for future innovations.